In the presence of indomethacin, an inhibitor of prostaglandin (PG) synthesis, the gonadotropin surge induces abnormal follicle rupture at the basolateral follicle sides, thus preventing effective ovulation in rats. This study was undertaken to analyze whether exogenous prostaglandin administration can overcome the antiovulatory action of indomethacin. Cycling rats were treated with vehicle (olive oil) or indomethacin (1 mg/rat) on the morning of proestrus. Rats treated with indomethacin were injected with different doses (50, 250, or 500 g/rat) of PGE 1 , PGE 2 , PGF 2␣ , or vehicle (saline) at 1900 h in proestrus. The ovulatory response was analyzed on the morning of estrus by evaluating follicle rupture and the location of the oocytes in serially sectioned ovaries. The number of oocytes in the oviducts was also counted in rats treated with the highest prostaglandin doses. In indomethacin-treated rats, most newly formed corpora lutea showed abnormal follicle rupture at the basolateral sides. In addition, invasion of the ovarian stroma and blood and lymphatic vessels by granulosa cells and follicular fluid was observed. Prostaglandins of the E series, and especially PGE 1 , inhibited abnormal follicle rupture and restored ovulation, although the number of oocytes in the oviducts were significantly decreased. PGF 2␣ was only partially effective in inhibiting abnormal follicle rupture and restoring ovulation. These data suggest that prostaglandins of the E series, and particularly PGE 1 , play a crucial role in ovulation by determining the targeting of follicle rupture at the apex, thus allowing release of oocytes to the periovarian space.
INTRODUCTION
Indomethacin has been widely used in studies on ovulation because of its consistent inhibition of the ovulatory process (reviewed in [1] [2] [3] [4] ). Previous studies with in vitro perfused ovaries [5, 6] indicated that indomethacin acts directly on the ovary. However, the effects of indomethacin on the tissue changes that occur in preovulatory follicles and the mechanism that mediates its antiovulatory action have not been fully established.
Most previous studies have assumed that indomethacin prevents follicle rupture [7] [8] [9] , most likely by inhibiting collagenolytic activity [2, 10] . In a recent study [11] we reported that abnormal follicle rupture, but not its inhibition, was responsible for the ovulatory failure in rats treated 1 This work was subsidized by a grant from CICYT, Spain. with indomethacin. More than 90% of follicles showed one or more points of rupture, and most oocytes were released to the ovarian interstitium or were retained inside the corpus luteum, although about 20% of oocytes were released to the periovarian space, and were therefore effectively ovulated. In addition, invasion of the ovarian stroma and blood vessels was observed, suggesting the existence of uncontrolled, but not inhibited, collagenolytic activity.
Indomethacin is a powerful inhibitor of prostaglandin synthesis [12, 13] and induces a rapid decrease in ovarian prostaglandin concentrations [14] . It is generally accepted that prostaglandin plays some still-undefined role in ovulation (reviewed in [4, 15] ). The involvement of prostaglandin in ovulation is based on several lines of evidence. First, prostaglandins (PGs) are formed in preovulatory follicles in response to the preovulatory LH surge, and reach their highest concentrations around the time of ovulation [14, 16, 17] . Second, nonsteroidal anti-inflammatory (indomethacin-like) drugs inhibit both prostaglandin synthesis and ovulation [1] [2] [3] [4] , and third, mice genetically deficient in cyclooxygenase-2 (COX-2) or PGE 2 receptors also show ovulatory failure [18, 19] . However, whether indomethacin blocks ovulation through COX inhibition or by alternative mechanisms, as well as the precise role of prostaglandin in ovulation remain to be elucidated. Indomethacin also affects other processes such as Ca 2ϩ flux [20, 21] and this, together with inconclusive data from prostaglandin replacement studies (reviewed in [4] ), has raised some doubts about the role of COX inhibition in the antiovulatory action of indomethacin-like drugs.
Several studies have been devoted to analyze whether the inhibitory action of indomethacin can be reversed by prostaglandin replacement. However, these studies have provided contradictory results; whereas some studies [6, 22] have found that PGE 2 , PGF 2␣ , or both can overcome the inhibitory effect of indomethacin, other studies [23, 24] have reported that these prostaglandins cannot restore ovulation in indomethacin-treated animals (reviewed in [4] ).
In this context, the objective of this study was to analyze the effect of prostaglandin replacement on follicle rupture and ovulation in indomethacin-treated rats. This would provide information on the mechanism underlying the antiovulatory action of indomethacin, and on the role of prostaglandins in ovulation.
MATERIALS AND METHODS

Animals and Treatments
Adult Wistar cycling rats were maintained under controlled light (14L: 10D, lights-on at 0500 h) and temperature conditions, and had free access to rat chow and tap water. Vaginal smears were taken daily, and only
FIG. 1. A and B)
Normally ruptured corpus luteum from a control rat. The site of rupture at the apex (arrow in A) and the theca externa surrounding the luteinized tissue (B) are clearly demarcated. A) ϫ90; B) ϫ175. C-E) Abnormally ruptured corpora lutea, grade I, from indomethacin-treated rats. The cumulus containing the oocyte (C) is entrapped inside the corpus luteum (C). Rupture sites at the basolateral side (large arrows in C-E) allow release of granulosa cells (short arrows in C and E) and follicular fluid (asterisk in C). C and E) ϫ175; D) ϫ350. animals displaying at least two consecutive 4-day estrous cycles were used. Experiments were performed according to the Guide for Care and Use of Laboratory Animals, and were approved by the Ethical Committee of the University of Córdoba.
Rats were injected s.c. at 1200 h in proestrus with 1 mg of indomethacin (Sigma Chemical Co., St. Louis, MO) in olive oil or vehicle (200 l). Indomethacin-treated rats were injected with vehicle (200 l of saline) or PGE 1 (50, 250, or 500 g/rat), PGE 2 (50, 250, or 500 g/rat), or PGF 2␣ (50, 250, or 500 g/rat; Sigma) at 1900 h in proestrus. This time schedule was selected because the expected time of the preovulatory surge, in our colony, was 1830 h in proestrus [25] . Prostaglandin doses in this range have been previously reported to be effective in inducing luteolysis or reversing indomethacin effects on ovulation [18, [26] [27] [28] . Animals (five per group) were killed at 0900 h in estrus.
Tissue Processing
The ovaries were dissected and fixed in Bouin-Hollande fluid for at least 24 h and processed for paraffin embedding. In animals injected with vehicle, indomethacin, and with the highest prostaglandin doses (500 g/ rat), the number of eggs in the oviducts were counted and expressed according to the number of newly formed corpora lutea in the corresponding ovaries. Whole ovaries were serially sectioned (6 m thick), stained with hematoxylin and eosin, and all sections were scored under a microscope.
Classification of Newly Formed Corpora Lutea
Newly formed corpora lutea were classified into three types depending on the characteristics of the rupture sites in the theca externa, and the degree of invasion of the ovarian interstitium by granulosa cells and follicular fluid. The first type was normally ruptured corpora lutea (NRCL), showing only one rupture site at the apex. The oocyte was released to the periovarian space (Fig. 1, A and B) . The second type was abnormally ruptured corpora lutea grade I (ARCL-I), showing several small rupture sites at the basolateral sides, including or not including a rupture site at the apex (Fig. 1, C-E) . Granulosa cells and small amounts of follicular fluid invaded adjacent areas of ovarian stroma. The oocyte was released to the periovarian space or, in most cases, it remained entrapped inside the corpus luteum. The third type was abnormally ruptured corpora lutea grade II (ARCL-II), showing at least a large rupture site at the basolateral sides. Oocytes were released to the ovarian interstitium (Figs. 2 and 4) or, less frequently, were entrapped inside the corpus luteum. Granulosa cells, cumulus cells, and abundant follicular fluid invaded the ovarian interstitium, eroded the blood and lymphatic vessel wall (Figs. 2-4) , producing emboli of granulosa cells and follicular fluid (Figs. 2-4 ). Oocytes were frequently observed inside blood or lymphatic vessels (Fig. 4, B and C) .
The percentages of the different types of corpora lutea were determined by two independent observers who were blind to the treatment. The percentages were established for the total number of newly formed corpora lutea.
Statistical Analysis
Statistical analysis was performed by ANOVA to test the existence of significant differences among groups. When significant differences existed, it was followed by the Dunnett method for multiple comparison among means Significance was considered at the 0.05 level, for n ϭ 5.
RESULTS
Control rats showed, on the morning of estrus (the day of ovulation), newly formed corpora lutea displaying normal morphological features. The rupture site at the apex and the theca externa surrounding the luteinized tissue were clearly observed (Fig. 1, A and B) . In indomethacin-treated rats, different types of newly formed corpora lutea were observed (Fig. 5) . Most corpora lutea corresponded to ARCL-II, although about 20% corresponded to NRCL. This paralleled the percentages of oocytes (Fig. 6 ) released to the interstitium (about 50%) and released to the periovarian space (about 30%). Most of the oocytes entrapped inside the corpora lutea corresponded to ARCL-I. Significantly (P Ͻ 0.05) fewer (about 20%) oocytes were found in the oviducts (Fig. 7) . Prostaglandin E 1 replacement restored ovulation and inhibited, in a dose-dependent manner, abnormal follicle rupture and invasion of the ovarian stroma. At lower doses, ARCL-II were absent, the number of NRCL was significantly (P Ͻ 0.05) higher, and the percentage of ARCL-I was relatively larger. At higher doses, abnormal follicle rupture was almost completely inhibited (Fig. 5) . In parallel, the number of oocytes released to the periovarian space was significantly (P Ͻ 0.05) higher at all doses, oocyte release to the interstitium was absent, and the number of oocytes entrapped inside the corpus luteum was significantly (P Ͻ 0.05) lower at middle doses and absent at the highest doses (Fig. 6) . However, significantly (P Ͻ 0.05) fewer oocytes were found in the oviducts in rats treated with the highest PGE 1 dose (Fig. 7) .
The effects of PGE 2 administration were roughly similar, although it was less effective and does not completely reverse ovulation or abnormal follicle rupture. The highest doses of PGE 2 were needed to inhibit large follicle rupture (ARCL-II) and to almost completely restore the number of oocytes released to the periovarian space. However, small follicle ruptures (ARCL-I) were still found, and about 10% of oocytes remained entrapped inside the corpus luteum. The number of oocytes recovered from the oviducts was significantly (P Ͻ 0.05) lower than in vehicle-treated rats.
PGF 2␣ was partially effective in inhibiting abnormal follicle rupture. The number of oocytes released to the periovarian space was significantly (P Ͻ 0.05) larger, although about 20% of oocytes remained entrapped inside the corpus luteum or were released to the interstitium, even with the highest dose. The number of oocytes in the oviducts was significantly (P Ͻ 0.05) smaller.
DISCUSSION
The mechanism by which follicle rupture is spatially targeted at the apex, allowing release of the oocyte to the periovarian space, is not known. A widely considered possibility is that the proteolytic activity, needed for the degradation of the follicle wall and perifollicular collagenous tissues, is limited to the apical zone (reviewed in [1] [2] [3] [4] ). In this sense, some studies have reported greater expression 
FIG. 7.
Percentage of oocytes recovered from the oviducts in rats injected with vehicle, indomethacin, or indomethacin plus PGE 1 (500 g), PGE 2 (500 g), or PGF 2␣ (500 g). a, Significant (P Ͻ 0.05) differences versus vehicle-treated rats; b, Significant (P Ͻ 0.05) differences versus indomethacin-treated rats (ANOVA and the Dunnett test for n ϭ 5).
of metalloproteinases at the apex of rabbit preovulatory follicles [29] , or greater gelatinolytic activity at the apex of rat preovulatory follicles [30] after hCG treatment. In this context, indomethacin-like drugs have been reported to prevent follicle rupture by inhibiting the tissue changes that happen at the apex of the follicle during ovulation [7] [8] [9] .
In a recent study [11] , we proposed an alternative hypothesis to the mechanism underlying targeting follicle rupture at the apex, based on the effects of indomethacin in cycling rats. Under this hypothesis, the balance between proteolytic enzymes and protease inhibitors is tilted toward proteolytic inhibition throughout the follicle wall. Local disruption of proteolytic inhibition at the apex could be the result of the release of local factors by the surface epithelium, by the fibroblasts of the tunica albuginea, or both. In the presence of indomethacin, proteolytic activity seems to be maintained throughout the follicle wall, thus allowing abnormal follicle rupture at the basolateral sides.
In the present study, prostaglandin replacement restored ovulation in indomethacin-treated rats, suggesting that the antiovulatory action of indomethacin is mediated by COX inhibition. Prostaglandins of the E series, especially PGE 1 , were the most effective in restoring ovulation. Several lines of evidence suggest that prostaglandins of the E type are those involved in ovulation. Prostaglandin E 2 concentrations show a 30-fold to 70-fold increase during the ovulatory process and are higher than those of PGF 2␣ at any time during ovulation [14, 31] . Mice with targeted disruption of the PGE 2 receptor (EP2) show ovulatory defects [19, 32] , and defective ovulation in COX-2 deficient mice can be restored by treatment with PGE 2 [18] .
Otherwise, PGF 2␣ was only partially effective in restoring ovulation. This agrees with previous studies suggesting that this prostaglandin does not play a key role in ovulation. Consistent with the data of the present study, PGF 2␣ does not completely restore ovulation in COX-2 deficient mice [18] . In addition, mice lacking the PGF 2␣ receptor do not show ovulatory defects [33] . The partial increase in the number of oocytes released to the periovarian space found in the present study as well as in previous studies [18] after PGF 2␣ replacement, could be due to its ability to bind to prostaglandin E receptors [34] .
Previous studies using prostaglandin replacement in indomethacin-treated animals have provided contradictory results. Whereas in some studies [6, 22] treatment with PGE 2 , PGF 2␣ , or both overcame the inhibitory effect of indomethacin; in others [23, 24] , prostaglandin treatment did not bring about any recovery (reviewed in [4] ). The reasons for these discrepancies are not known, but they could be due to the use of different species and experimental models, as well as different ways to evaluate the ovulatory response. In most studies, ovulation was detected by counting oocytes in the oviduct, and few [11, 35] have exhaustively examined the location of the oocytes in the ovary. In the present study, each corpus luteum was systematically scored in serial sections to look for the existence of follicle ruptures and the location of the oocyte. However, whether oocytes released to the periovarian space (in indomethacin-treated rats) were located in the oviduct or retained inside the periovarian cavity, was not directly assessed because intact ovarian bursa was not processed. However, counting oocytes in the oviduct indicated that even in those cases in which all (PGE 1 -treated rats) or nearly all (PGE 2 -treated rats) oocytes were released to the periovarian space, the percentage of oocytes found in the oviducts was significantly decreased. This agrees with the observation that oocytes adhered to the ovarian surface in indomethacin-treated rats in the present study (data not shown), and with similar findings reported previously in indomethacin-treated rats supplemented with PGE 2 [36] . This suggests the existence of a failure in the transport of eggs to the oviduct in indomethacin-treated rats that was not completely reversed by prostaglandin supplementation. In this sense, the evaluation of the ovulation rate by counting eggs in the oviduct could be inadequate, and could be responsible for some inconsistencies in the literature. Additional studies analyzing oocyte transport to the oviduct in indomethacintreated rats are needed.
Abnormal follicle rupture is responsible for the antiovulatory action of indomethacin [11] . Prostaglandins acted in a dose-dependent manner by inhibiting abnormal follicle rupture. At lower doses, PGE 1 , and to a lesser extent PGE 2 , inhibited large follicle ruptures at the basolateral sides, thus preventing release of the oocytes to the interstitium, as well as invasion of the ovarian stroma by granulosa cells. At higher doses, follicle rupture at the basolateral sides was almost completely inhibited. The different degree of follicle rupture and invasion of the stroma (grades I and II) is suggestive of the existence of a different proteolytic activity. Espey [3, 37] introduced the concept of ovulation as an acute inflammatory reaction, based on the histological and biochemical similarities between both processes. The data of the present study suggest that prostaglandins of the E series play a regulatory role in ovulation by inhibiting follicle rupture at the basolateral sides, probably by modulating proteolytic activity. Prostaglandins play both proinflammatory and anti-inflammatory roles during inflammatory processes. Particularly, PGE 1 has been found to be effective as an anti-inflammatory agent and may act by inhibiting collagenase gene expression [38, 39] . The anti-inflammatory effects of prostaglandins could explain the apparently paradoxical effect of PGE 2 , which has been reported to inhibit ovulation in about 50% of gonadotropin-primed immature rats [24] .
The invasive capacity of granulosa cells and follicular fluid in indomethacin-treated rats was impressive. Invasion of the ovarian stroma and of blood and lymphatic vessels provides evidence of their destructive capacity. Some data of this study suggest that blood vessel walls were eroded by follicular fluid (see Fig. 2 ), which agrees with the presence of metalloproteinases in follicular fluid [40] . Such a proteolytic activity of follicular fluid and granulosa cells should be tightly regulated to prevent proteolytic damage to the ovary while allowing the tissue degradation needed for oocyte release. PGE 1 seems to play a key role in controlling proteolytic activity during ovulation, as well as in the mechanism underlying spatial targeting of follicle rupture at the ovarian surface.
